MTOR and lymphoma: We also detected changes in the expression of proteins involved in the proliferation-related mTOR and NF-κB pathways, such as LAMTOR1 and NFKBID (Figure S3), which was consistent with a previous study describing a multiprotein supercomplex involved in the control of oncogenic signaling in lymphoma [31].